Видео с ютуба Aaron Kesselheim

NEJM Interview: Dr. Aaron Kesselheim on a recent Supreme Court ruling on patents for diagnostic t...

Dr. Aaron Kesselheim Believes Drug Ads Should Be Banned | CNBC

Podcast 22: Interview with Aaron Kesselheim about his meta-analysis of the efficacy of proprietar...

7/25/2019 - Session 6: Aaron Kesselheim

NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to th...

Dr. Aaron Kesselheim Discusses Comparative Effectiveness Research

Merck concealed Vioxx safety risks

CER & Academic Detailing: Harvard's Dr. Kesselheim Explains

U.S. Drug Prices: Whatever the market will bear

Variation in Endpoints for FDA Approved Migraine Therapies

In Search of US Pharmaceutical Policy Innovation

Aducanumab (Aduhelm) for the Treatment of Alzheimers: Aaron Kesselheim and Jason Karlawish

What to Expect from Trump’s Executive Order Asking for Drug Cost Reduction

Aaron Kesselheim: Law, Policy, and Health

Expert Who Resigned From FDA Committee Over Alzheimer’s Drug Explains His Reasoning

Patient Demand for Antibiotics: Highlight from Battling Drug-Resistant Superbugs

Спор вокруг лечения болезни Альцгеймера: последствия ускоренного одобрения лекарственных препаратов

4/1/2015: Session 5 - Kesselheim

The Alzheimer’s Treatment Controversy: Implications of Accelerated Drug Approvals

Petrie-Flom Center's Eighth Annual Health Law Year in P/Review: Challenges in Drug Pricing